Sales decline
Galapagos Drops Jyseleca in Europe, Lowers Sales Outlook
Galapagos has suffered a significant setback as it decided not to submit a Marketing Authorization Application (MAA) for its drug ...
CDMO Experiences Downturn at Merck KGaA as COVID-Related Sales Plunge, Says CFO
Merck KGaA is facing the challenges it anticipated for 2023, with its contract manufacturing division and process solutions arm experiencing ...
Karyopharm reduces employees by 20% as Xpovio sales for blood cancer remain stagnant
Source – Karyopharm Therapeutics Karyopharm Therapeutics, faced with stagnant sales of its only approved product, Xpovio (selinexor), has announced a ...
Bristol Myers lowers the company’s 2023 revenue forecast for Revlimid by $1 billion
Bristol Myers Squibb (BMS) had a promising long-term outlook after securing FDA approvals for three drugs with peak sales potential ...
AbbVie Raises Profit Expectations Despite Q2 Decrease in Humira and Imbruvica Sales
AbbVie executives express satisfaction with the introduction of Humira biosimilars in the US, despite facing significant revenue declines for both ...
Bayer anticipates a more bleak 2023 as decreased glyphosate sales support the argument for a separation
As calls for a business separation at Bayer grow louder, the company’s weedkiller performance is providing further support for the ...
